Stoke Therapeutics, Inc. (STOK) on GreekSoup https://greeksoup.ai/stocks/us/stok/ Every dated entry in the public record on Stoke Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Stoke Therapeutics, Inc.: Form 144, EDWARD KAYE plans to sell 1,496,042 shares worth $38.4 million around 21 October 2026https://greeksoup.ai/stocks/us/stok/planned-sales/us:STOK:planned-sale:2026-10-21:13ae2820ebWed, 21 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: short interest 10,256,830 shares at the 15 October 2026 settlement, 12.33 days to coverhttps://greeksoup.ai/stocks/us/stok/short-interest/us:STOK:short-interest:2026-10-15:744582e9b9Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Form 144, JONATHAN D ALLAN plans to sell 627 shares worth $16,308 around 2 October 2026https://greeksoup.ai/stocks/us/stok/planned-sales/us:STOK:planned-sale:2026-10-02:0d90015b18Fri, 02 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Allan Jonathan (GENERAL COUNSEL & CORP SEC) sold 627 shares (under a trading plan set in advance) at $26.33 on 2 October 2026, $16,509https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-10-02:dd54088d80Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 1,051 shares (under a trading plan set in advance) at $26.16 on 1 October 2026, $27,494https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-10-02:a361026644Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Schedule 13G filed by BIOTECHNOLOGY VALUE FUND L P, 5.6% of the classhttps://greeksoup.ai/stocks/us/stok/holders/us:STOK:schedule-13:2026-09-30:33e38c6b5bWed, 30 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: short interest 11,505,410 shares at the 30 September 2026 settlement, 10.17 days to coverhttps://greeksoup.ai/stocks/us/stok/short-interest/us:STOK:short-interest:2026-09-30:a42ba26664Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/stok/filings/us:STOK:filing:2026-09-25:621ffa0280Fri, 25 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: short interest 11,150,236 shares at the 15 September 2026 settlement, 17.31 days to coverhttps://greeksoup.ai/stocks/us/stok/short-interest/us:STOK:short-interest:2026-09-15:4917847b77Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 3,945 shares (under a trading plan set in advance) at $30.51 on 1 September 2026, $120,370https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-09-03:37001afc52Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 1,600 shares (under a trading plan set in advance) at $31.06 on 1 September 2026, $49,691https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-09-03:68ab3c1528Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: short interest 11,203,427 shares at the 31 August 2026 settlement, 11.87 days to coverhttps://greeksoup.ai/stocks/us/stok/short-interest/us:STOK:short-interest:2026-08-31:ef5c308c80Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 4,525 shares at $32.01 on 18 August 2026, $144,833https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-18:1a91549511Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 242 shares at $32.47 on 18 August 2026, $7,857https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-18:a36e28cb38Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Kaye Edward M. Md (Director) sold 11,930 shares at $32.01 on 18 August 2026, $381,846https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-18:1a91f33965Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Kaye Edward M. Md (Director) sold 637 shares at $32.47 on 18 August 2026, $20,682https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-18:affd0d3a6cTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Allan Jonathan (GENERAL COUNSEL & CORP SEC) sold 2,716 shares at $32.01 on 18 August 2026, $86,932https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-18:41ef685523Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Allan Jonathan (GENERAL COUNSEL & CORP SEC) sold 145 shares at $32.47 on 18 August 2026, $4,708https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-18:815508cd69Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Schedule 13G/A filed by Lynx1 Capital Management LP, 6.5% of the classhttps://greeksoup.ai/stocks/us/stok/holders/us:STOK:schedule-13:2026-08-14:2bb41a3897Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: short interest 12,978,102 shares at the 14 August 2026 settlement, 12.70 days to coverhttps://greeksoup.ai/stocks/us/stok/short-interest/us:STOK:short-interest:2026-08-14:89042c63daFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Schedule 13G/A filed by The Toronto-Dominion Bank, 4.9% of the classhttps://greeksoup.ai/stocks/us/stok/holders/us:STOK:schedule-13:2026-08-12:e785bfee8cWed, 12 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Schedule 13G/A filed by FMR LLC, 8.5% of the classhttps://greeksoup.ai/stocks/us/stok/holders/us:STOK:schedule-13:2026-08-06:0bbfae937bThu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 5,907 shares (under a trading plan set in advance) at $28.95 on 3 August 2026, $171,008https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-05:f0924c4419Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Ticho Barry (CHIEF MEDICAL OFFICER) sold 1,269 shares (under a trading plan set in advance) at $29.45 on 3 August 2026, $37,377https://greeksoup.ai/stocks/us/stok/insiders/us:STOK:insider:2026-08-05:3751647a85Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc. Q2 FY2026 results: revenue $9 million, net income -$62 millionhttps://greeksoup.ai/stocks/us/stok/results/fy2026-q2/us:STOK:result:2026-08-03:b66647ece4Mon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/stok/filings/us:STOK:filing:2026-08-03:16632e089eMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/stok/filings/us:STOK:filing:2026-08-03:b5ba706476Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/stok/filings/us:STOK:filing:2026-08-03:f4100d38d7Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/stok/filings/us:STOK:filing:2026-08-03:6d85a0cf56Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: Form 144, BARUCH TICHO plans to sell 20,967 shares worth $605,108 around 3 August 2026https://greeksoup.ai/stocks/us/stok/planned-sales/us:STOK:planned-sale:2026-08-03:76937e0160Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Stoke Therapeutics, Inc.: short interest 15,809,687 shares at the 31 July 2026 settlement, 27.67 days to coverhttps://greeksoup.ai/stocks/us/stok/short-interest/us:STOK:short-interest:2026-07-31:fc5ea13c1aFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>